Duality Biotherapeutics Inc Sustainability Reports
Duality Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing next-generation antibody-drug conjugate (ADC) therapeutics for patients with cancer and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 254900HZFACBOBP9HN21
FIGI: BBG014ZTYJW4
4 reports from 2024 to 2025
